Publication Name	World Journal of Rheumatology
Manuscript ID	39892
Country	United States

Received	2018-05-17 10:28
Peer-Review Started	2018-05-18 08:33
To Make the First Decision	2018-06-14 00:18
Return for Revision	2018-07-03 01:32
Revised	2018-11-15 08:00
Second Decision	2018-11-29 03:45
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2018-11-29 23:14
Articles in Press	2018-11-29 23:14
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2018-12-04 01:48
Publish the Manuscript Online	2018-12-10 09:03

ISSN	2220-3214 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Rheumatology
Manuscript Type	Editorial
Article Title	Maligned non-steroidal anti-inflammatory drugs: Misunderstanding of their safety profile in patients with renal insufficiency
Manuscript Source	Invited Manuscript
All Author List	Bruce M Rothschild
ORCID	Author(s) ORCID Number Bruce M Rothschild http://orcid.org/0000-0003-1327-6615
Funding Agency and Grant Number
Corresponding Author	Bruce M Rothschild, MD, Professor, Department of Medicine, Indiana University, Ball Memorial Hospital, 4400 Forbes Ave, Muncie, IN 47304, United States. spondylair@gmail.com
Key Words	Non-steroidal anti-inflammatory drugs; Renal function; Safety; Toxicity
Core Tip	Non-steroidal anti-inflammatory drugs are safe when appropriately dosed and renal function monitored. Evaluation for complete blood count, comprehensive metabolic panel and urinalysis within two weeks of initiation, at dose augmentation and with use of interacting or hemodynamically-altering concomitant medications, and again at a month and at three month intervals provides an appropriate monitoring regimen.
Publish Date	2018-12-10 09:03
Citation	Rothschild BM. Maligned non-steroidal anti-inflammatory drugs: Misunderstanding of their safety profile in patients with renal insufficiency. World J Rheumatol 2018; 8(1): 1-4
URL	http://www.wjgnet.com/2220-3214/full/v8/i1/1.htm
DOI	http://dx.doi.org/10.5499/wjr.v8.i1.1

Full Article (PDF)	WJR-8-1.pdf
Full Article (Word)	WJR-8-1.doc
Manuscript File	39892-Review.docx
Answering Reviewers	39892-Answering reviewers.pdf
Audio Core Tip	39892-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	39892-Conflict-of-interest statement.pdf
Copyright License Agreement	39892-Copyright assignment.pdf
Peer-review Report	39892-Peer-review(s).pdf
Scientific Misconduct Check	39892-Scientific misconduct check.pdf
Scientific Editor Work List	39892-Scientific editor work list.pdf